Claudia Gottstein
Affiliations: | University of California, Santa Barbara, Santa Barbara, CA, United States |
Google:
"Claudia Gottstein"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pearce HA, Qian H, Connell TU, et al. (2019) Site-Specific Glycation and Chemo-enzymatic Antibody Sortagging for the Retargeting of rAAV6 to Inflamed Endothelium. Molecular Therapy. Methods & Clinical Development. 14: 261-269 |
| Greineder CF, Hood ED, Yao A, et al. (2016) Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Gosk S, Moos T, Gottstein C, et al. (2008) VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochimica Et Biophysica Acta. 1778: 854-63 |
| Ding BS, Hong N, Murciano JC, et al. (2008) Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature. Blood. 111: 1999-2006 |
| Danielyan K, Ding BS, Gottstein C, et al. (2007) Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema. The Journal of Pharmacology and Experimental Therapeutics. 321: 947-52 |
| Unruh M, Grunow A, Gottstein C. (2005) Systemic coagulation parameters in mice after treatment with vascular targeting agents. Thrombosis Journal. 3: 21 |
| Ding BS, Gottstein C, Grunow A, et al. (2005) Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. Blood. 106: 4191-8 |
| Borchmann P, Treml JF, Hansen H, et al. (2003) The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma. Blood. 102: 3737-42 |
| Philipp J, Dienst A, Unruh M, et al. (2003) Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 905-10 |
| Gottstein C, Wels W, Ober B, et al. (2001) Generation and characterization of recombinant vascular targeting agents from hybridoma cell lines Biotechniques. 30: 190-194, 196, 198 pa |